Enterovirus Infections: Clinical Trials

465 trials for Enterovirus Infections, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

351 completed, 49 unknown, 17 recruiting, 14 withdrawn. 142 Phase 3, 107 Phase 4, 68 Phase 2, 59 Not applicable, 44 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 3142Completed 120, Unknown 7, Withdrawn 5, Terminated 4, Recruiting 3, Active not recruiting 2, Not yet recruiting 1
Phase 4107Completed 82, Unknown 15, Not yet recruiting 3, Withdrawn 3, Recruiting 2, Active not recruiting 1, Terminated 1
Phase 268Completed 53, Recruiting 4, Terminated 4, Unknown 3, Active not recruiting 2, Withdrawn 2
Not applicable59Completed 37, Unknown 8, Active not recruiting 5, Not yet recruiting 3, Withdrawn 3, Recruiting 2, Terminated 1
Phase 144Completed 33, Unknown 5, Recruiting 3, Active not recruiting 1, Not yet recruiting 1, Terminated 1

Follow Enterovirus Infections: new trials by email Literature Review of Enterovirus Infections trials Research Report on Enterovirus Infections

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study of BK1803 in Healthy Infants
BK1803, GOBIK Aqueous Suspension Syringes, Bimmugen® Injection - Pertussis, Diphtheria
Phase 3RecruitingTanabe Pharma Corporation3442026-10-212026-11-12
A Phase I/II Clinical Trial of the Diphtheria, Tetanus, Acellular Component Pertussis and Sabin Inactivated Poliomyelitis Vaccine Adsorbed
Diphtheria, Tetanus, Acellular Component Pertussis and Sabin Inactivated Poliomyelitis Vaccine Adsorbed, Diphtheria, Tetanus and Acellular Component Pertussis Combined Vaccine, Diphtheria, Tetanus and Acellular Component Pertussis Combined Vaccine+Inactivated Poliomyelitis Vaccine Made From Sabin Strains - Diphtheria, Pertussis
Phase 1 / Phase 2RecruitingInstitute of Medical Biology, Chinese Academy of Medical Sciences3802026-10-112026-10-23
CHIPCAT and HFMD-PREP for HFMD Prevention in Childcare Centres in Kota Kinabalu
HFMD-PREP (HFMD Prevention and Response Enhancement Programme) - Hand, Foot and Mouth Disease, Infection Control
Not applicableNot yet recruitingHelmy Sajali, MD, MPH7802026-10-012026-10-13
Risk Factors and Outcomes of Hepatitis A in Children
Hepatitis A, Acute Hepatitis
Not yet recruitingAssiut University1902026-09-262026-09-30
Bridging Clinical Trial of EV71 Vaccine in Vietnamese Children
EV71 vaccine - Hand, Foot, and Mouth Disease (HFMD), Enterovirus 71 Infection
Not applicableNot yet recruitingSinovac Biotech Co., Ltd3202026-09-192026-09-01
Safety and Immunogenicity of a Recombinant Poliomyelitis Vaccine (rPV) in Comparison With IPOL Vaccine in Healthy Adults
Recombinant Poliomyelitis Vaccine (rPV), Inactivated Poliomyelitis Vaccine (IPOL) - Polio Immunity
Phase 1RecruitingSerum Institute of India Pvt. Ltd.362026-09-112026-09-29
Study on the Long-Term Persistence of Immunity Induced by Inactivated Hepatitis A Vaccine
Healive®, Havrix® - Hepatitis A
RecruitingSinovac Biotech Co., Ltd1062026-08-022026-10-22
Protective Efficacy , Immunogenicity and Safety of the Tetravalent Inactivated Enterovirus Vaccine (Vero Cell).
Tetravalent Inactivated Enterovirus Vaccine (Vero Cell), Placebo - Hand, Foot, and Mouth Disease(HFMD), Herpangina
Phase 3Not yet recruitingSinovac Biotech Co., Ltd60002026-05-012026-05-28
A Study to Evaluate the Mucosal Intestinal Immunity to Poliovirus Type-2 of nOPV2 at Birth Dose in Healthy IPV Vaccinated Infants
nOPV2 - Poliomyelitis
Phase 3RecruitingFidec Corporation7402026-04-302026-09-09
Effects of Virtual Walking on Chronic Pain and Psychological Distress for Individuals With Severe Mobility Impairment
Virtaul walking, Passive observing video - Severe Mobility Impairment, Spinal Cord Injuries (SCI)
Not applicableActive not recruitingThe Hong Kong Polytechnic University482026-04-022026-09-15
Comparative Evaluation of Oral Ursodeoxycholic Acid in Reducing Bilirubin Levels Among Patients With Acute Viral Hepatitis
Ursodeoxycholic Acid, Supportive Care - Hepatitis A, Hepatitis E Virus Infection
Not applicableNot yet recruitingCombined Military Hospital, Pakistan882026-04-012026-04-13
Effects of Whole-body Electrical Muscle Stimulation Exercise on Adults With Neuromuscular Disease
Whole-body Electrical Muscle Stimulation Exercise - Neuromuscular Diseases (NMD), Amyotrophic Lateral Sclerosis
Not applicableActive not recruitingUniversity of Missouri-Columbia502026-03-102026-11-06
Neonatal Enterovirus Infections in Italy: Virological Characterization, Genomic and Clinical-epidemiological Insights on Echovirus 11
Enterovirus, Clinical Syndrome
RecruitingFondazione IRCCS Policlinico San Matteo di Pavia16002026-02-012026-03-27
the Five-year Antibody Persistence After Immunization With IPV, MMR and HepA-L Vaccines
Polio, Measles
Not yet recruitingChina National Biotec Group Company Limited6002026-01-302026-01-14
A Study to Evaluate the 17-Year Immune Persistence of a Single Dose of Inactivated Hepatitis A Vaccine
Inactivated HAV vaccine, Attenuated live HAV vaccine - Hepatitis A
CompletedSinovac Biotech Co., Ltd1052026-01-132026-10-02
Phase I Clinical Trial of Enterovirus Type71 - Coxsackievirus Type A16 Bivalent Vaccine
Low Dose Enterovirus Type71 - Coxsackievirus Type A16 bivalent vaccine, inactivated (human diploid cell), Medium Dose Enterovirus Type71 - Coxsackievirus Type A16 bivalent vaccine, inactivated (human diploid cell), High Dose Enterovirus Type71 - Coxsackievirus Type A16 bivalent vaccine, inactivated (human diploid cell) - Hand, Foot and Mouth Disease (HFMD), HFMD
Phase 1Not yet recruitingInstitute of Medical Biology, Chinese Academy of Medical Sciences1442025-12-302026-01-08
Risk Assessment of Community Spread of Multiple Endemic Infectious Diseases in a One Health Perspective
Dengue, Chikungunya
RecruitingInstitut Pasteur du Cambodge100002025-12-182026-01-22
Phase IV Clinical Study of Sequential Vaccination of Sabin Strain and Wild Strain Inactivated Poliovirus Vaccine
2wIPV+1sIPV, 1wIPV+2sIPV, 3wIPV - Poliomyelitis
Phase 4RecruitingSinovac Biotech Co., Ltd4802025-11-272026-03-09
Study of Co-administered (Types 1 & 2) Novel Oral Poliomyelitis Vaccines Evaluation
Novel Oral Polio Vaccine Type 1 (nOPV1), Novel Oral Polio Vaccine Type 2 (nOPV2), Placebo (Sterile Water) - Poliomyelitis
Phase 2RecruitingPATH6752025-11-112026-01-09
Immunity With Acute Hepatits A
Hepatitis A, Hepatitis A Virus
Not yet recruitingAssiut University502025-10-012025-04-24

Showing 20 of 465. Sign in to see all of them.

Narrower conditions

Poliomyelitis (263)  ·  Tetanus (115)  ·  Diphtheria (114)  ·  Hepatitis B (90)  ·  Whooping Cough (85)  ·  Hepatitis A (82)  ·  Haemophilus Infections (71)  ·  Hand, Foot and Mouth Disease (59)  ·  Postpoliomyelitis Syndrome (28)  ·  Hepatitis (18)  ·  Virus Diseases (14)  ·  Measles (11)  ·  Spinal Cord Injuries (9)  ·  Hepatitis C (8)

Broader conditions

Infections (458)  ·  Picornaviridae Infections (458)  ·  RNA Virus Infections (457)  ·  Virus Diseases (451)  ·  Neuroinflammatory Diseases (294)  ·  Nervous System Diseases (293)  ·  Central Nervous System Diseases (292)  ·  Central Nervous System Infections (291)  ·  Myelitis (284)  ·  Spinal Cord Diseases (283)  ·  Neuromuscular Diseases (281)  ·  Digestive System Diseases (151)  ·  Hepatitis, Viral, Human (148)  ·  Liver Diseases (148)

Interventions

Hepatitis A Vaccines (29)  ·  Poliovirus Vaccine, Inactivated (28)  ·  diphtheria-tetanus-acellular pertussis-inactivated poliovirus-Haemophilus influenzae b conjugate-hepatitis B vaccine (27)  ·  Tetanus Toxoid (14)  ·  Diphtheria-Tetanus-acellular Pertussis Vaccines (12)  ·  Pentavac (11)  ·  DTaP-IPV-HB-PRP-T vaccine (10)  ·  Blood Specimen Collection (9)  ·  Hepatitis B Vaccines (9)  ·  Heptavalent Pneumococcal Conjugate Vaccine (9)  ·  Engerix-B (8)  ·  pentacel (8)  ·  twinrix (8)  ·  13-valent pneumococcal vaccine (7)  ·  Haemophilus influenza type b polysaccharide vaccine-tetanus toxin conjugate (7)

Sponsors

GlaxoSmithKline (71)  ·  Sanofi Pasteur, a Sanofi Company (48)  ·  Sinovac Biotech Co., Ltd (46)  ·  Centers for Disease Control and Prevention (16)  ·  Institute of Medical Biology, Chinese Academy of Medical Sciences (16)  ·  Sanofi (15)  ·  Aga Khan University (12)  ·  Jiangsu Province Centers for Disease Control and Prevention (12)  ·  Fidec Corporation (10)  ·  LG Chem (8)  ·  PATH (8)  ·  Gilead Sciences (7)  ·  Merck Sharp & Dohme LLC (6)  ·  Chinese Academy of Medical Sciences (5)  ·  Enimmune Corporation (5)

Countries

China (111)  ·  United States (47)  ·  Bangladesh (21)  ·  Belgium (19)  ·  France (19)  ·  Germany (17)  ·  South Korea (16)  ·  Thailand (13)  ·  Pakistan (11)  ·  Canada (10)  ·  Panama (10)  ·  Philippines (10)  ·  Czechia (9)  ·  Finland (9)  ·  Italy (9)

Top investigators

Yuemei Hu (5)  ·  Zhaojun Mo, Master (5)  ·  Fengcai Zhu, Master (4)  ·  Ingrid Kromann (4)  ·  Natchaya Kunanitthaworn, MD (3)  ·  Tavitiya Sudjaritruk, MD, PhD (3)  ·  Yan-pin Li, MD (3)  ·  Abhijeet Anand, MBBS, MPH (2)  ·  Beth Kirkpatrick, M.D. (2)  ·  Fubao Ma (2)

Results publications

PMID 32710245, PMID 26873055, PMID 27553375, PMID 32867698, PMID 21366801, PMID 22153001, PMID 22426327, PMID 23372725, PMID 24260259, PMID 24508042, PMID 26190091, PMID 28340322, PMID 32273184, PMID 33487470, PMID 38218668, PMID 39088987, PMID 40318674, PMID 10025486, PMID 11855555, PMID 16708058, PMID 16713921, PMID 17090650, PMID 17152004, PMID 17259872, PMID 17429085, PMID 17947390, PMID 17980513, PMID 17990291, PMID 18233994, PMID 18816600, PMID 19117896, PMID 19952980, PMID 20448468, PMID 20616762, PMID 20630640, PMID 20856164, PMID 20955461, PMID 21219984, PMID 21241735, PMID 21289531, PMID 21334243, PMID 21372751, PMID 21441781, PMID 21807056, PMID 22001281, PMID 22157567, PMID 22158682, PMID 22233167, PMID 22273029, PMID 22349525

NIH funding

2014 (3), 2015 (2), 2018 (2), 2008 (1), 2009 (1), 2017 (1), 2019 (1), 5UM1AI148684-04 (1), R01AI130398 (1), R01DA017476 (1), R01NR016942 (1)